首页> 外文期刊>Tropical Journal of Pharmaceutical Research >A preliminary study of in vitro and in vivo synergistic effects of ciprofloxacin and D-tyrosine against Pseudomonas aeruginosa isolates
【24h】

A preliminary study of in vitro and in vivo synergistic effects of ciprofloxacin and D-tyrosine against Pseudomonas aeruginosa isolates

机译:西氟哌辛辛和酪氨酸对Pseudomonas铜绿假单胞菌的体外和体内协同作用的初步研究

获取原文
           

摘要

Purpose: To investigate the synergistic antimicrobial effects of ciprofloxacin and D-tyrosine against drug-resistant bacteria. Method: The antimicrobial effects of ciprofloxacin and D-tyrosine on clinical isolates of multidrug-resistant (MDR) Pseudomonas aeruginosa (P. aeruginosa) no. 3556 were determined in vitro based on time-kill curve, and in vivo in P. aeruginosa-zebrafish infection model. Furthermore, 30 clinical isolates of multidrug-resistant P. aeruginosa were used in vitro to ascertain the synergistic effect of the two agents. Results: Combined use of ciprofloxacin and D-tyrosine produced synergistic effects against the clinical isolate of P. aeruginosa no. 3556 in vitro and in vivo. Synergism occurred in 96.67 % (95 % CI, range 83.33 - 99.41 %) of the clinical isolates, and ciprofloxacin dose was reduced in 90 % (95 % CI, range 74.38 - 96.54 %) of the clinical isolates in vitro. Conclusion: These preliminary results suggest that the combination of ciprofloxacin and D-tyrosine is a promising therapeutic strategy against MDR P. aeruginosa infections.
机译:目的:探讨环丙沙星和D-酪氨酸对抗耐药细菌的协同抗微生物作用。方法:CiProfloxacin和D-酪氨酸对多药抗性(MDR)假鼠铜绿假单胞菌(P. Aerginosa)NO临床分离株的抗微生物效应。基于时间杀死曲线,在P. Aerginosa-Zebrafish感染模型中的体外测定3556。此外,在体外使用30多药抗性P.铜绿假单胞菌的临床分离株,以确定两种试剂的协同效应。结果:联合使用环丙沙星和D-酪氨酸对P.铜绿假单胞菌的临床分离物产生协同作用。 3556体外和体内。在临床分离物中96.67%(95%CI,范围83.33-99.41%)发生的协同作用,并且环丙沙星剂量在体外临床分离物的90%(95%CI,范围74.38-96.54%)。结论:这些初步结果表明,CiProfloxacin和D-酪氨酸的组合是针对MDR P.铜绿假单胞菌感染的有前途的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号